OraSure Technologies, Inc. (OSUR) Position Boosted by ETRADE Capital Management LLC
ETRADE Capital Management LLC increased its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 43.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,402 shares of the medical instruments supplier’s stock after buying an additional 5,566 shares during the quarter. ETRADE Capital Management LLC’s holdings in OraSure Technologies were worth $347,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in OSUR. Emerald Advisers Inc. PA purchased a new position in OraSure Technologies during the fourth quarter worth about $12,518,000. Fuller & Thaler Asset Management Inc. lifted its position in OraSure Technologies by 175.6% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 898,397 shares of the medical instruments supplier’s stock worth $20,214,000 after buying an additional 572,397 shares during the period. SG Capital Management LLC purchased a new position in OraSure Technologies during the third quarter worth about $9,205,000. Arrowstreet Capital Limited Partnership purchased a new position in OraSure Technologies during the fourth quarter worth about $7,583,000. Finally, Allianz Asset Management GmbH lifted its position in OraSure Technologies by 4,140.9% during the fourth quarter. Allianz Asset Management GmbH now owns 403,096 shares of the medical instruments supplier’s stock worth $7,602,000 after buying an additional 393,591 shares during the period. Hedge funds and other institutional investors own 93.67% of the company’s stock.
Shares of OraSure Technologies, Inc. (NASDAQ OSUR) opened at $18.60 on Wednesday. The company has a market capitalization of $1,129.72, a PE ratio of 36.33, a price-to-earnings-growth ratio of 5.17 and a beta of 1.60. OraSure Technologies, Inc. has a 12 month low of $10.75 and a 12 month high of $23.01.
In other news, EVP Brian Smith sold 20,000 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $17.97, for a total value of $359,400.00. Following the completion of the sale, the executive vice president now owns 28,075 shares in the company, valued at $504,507.75. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stephen S. Phd Tang sold 23,333 shares of the stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $17.97, for a total value of $419,294.01. Following the completion of the sale, the director now owns 59,749 shares of the company’s stock, valued at approximately $1,073,689.53. The disclosure for this sale can be found here. Corporate insiders own 6.40% of the company’s stock.
Several equities analysts recently weighed in on the company. ValuEngine upgraded OraSure Technologies from a “hold” rating to a “buy” rating in a research report on Friday, March 2nd. BidaskClub lowered OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 15th. Zacks Investment Research lowered OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, February 13th. Finally, Canaccord Genuity restated a “buy” rating and set a $24.00 price target on shares of OraSure Technologies in a research note on Friday, February 2nd. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. OraSure Technologies has a consensus rating of “Buy” and a consensus price target of $22.25.
ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2018/03/14/orasure-technologies-inc-osur-position-boosted-by-etrade-capital-management-llc.html.
About OraSure Technologies
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.